• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

凋亡抑制蛋白(XIAP)介导的半胱天冬酶抑制作用的解除对Smac的第二个和第三个BIR结构域的需求。

Requirement of both the second and third BIR domains for the relief of X-linked inhibitor of apoptosis protein (XIAP)-mediated caspase inhibition by Smac.

作者信息

Huang Yihua, Rich Rebecca L, Myszka David G, Wu Hao

机构信息

Department of Biochemistry, Weill Medical College and Graduate School of Medical Sciences of Cornell University, New York, NY 10021, USA.

出版信息

J Biol Chem. 2003 Dec 5;278(49):49517-22. doi: 10.1074/jbc.M310061200. Epub 2003 Sep 25.

DOI:10.1074/jbc.M310061200
PMID:14512414
Abstract

The inhibitor of apoptosis proteins (IAP) are endogenous caspase inhibitors in the metazoan and characterized by the presence of baculoviral IAP repeats (BIR). X-linked IAP (XIAP) contains three BIR domains and directly inhibits effector caspases such as caspase-7 via a linker_BIR2 fragment and initiator caspases such as caspase-9 via the BIR3 domain. A mitochondrial protein Smac/DIABLO, which is released during apoptosis, antagonizes XIAP-mediated caspase inhibition by interacting directly with XIAP. Here, using glutathione S-transferase pulldown and caspase activity assay, we show that Smac is ineffective in relieving either caspase-7 or caspase-9 inhibition by XIAP domain fragments. In addition, Smac forms a ternary complex with caspase-7 and linker_BIR2, suggesting that Smac/linker_BIR2 interaction does not sterically exclude linker_BIR2/caspase-7 interaction. However, Smac is effective in removing caspase-7 and caspase-9 inhibition by XIAP fragments containing both the BIR2 and BIR3 domains. Surface plasmon resonance measurements show that Smac interacts with the BIR2 or BIR3 domain in micromolar dissociation constants. On the other hand, Smac interacts with an XIAP construct containing both BIR2 and BIR3 domains in a subnanomolar dissociation constant by the simultaneous interaction of the Smac dimer with the BIR2 and BIR3 domains of a single XIAP molecule. This 2:1 Smac/XIAP interaction not only possesses enhanced affinity but also sterically excludes XIAP/caspase-7 interaction, demonstrating the requirement of both BIR2 and BIR3 domains for Smac to relieve XIAP-mediated caspase inhibition.

摘要

凋亡抑制蛋白(IAP)是后生动物体内的内源性半胱天冬酶抑制剂,其特征是存在杆状病毒IAP重复序列(BIR)。X连锁IAP(XIAP)包含三个BIR结构域,通过连接子_BIR2片段直接抑制效应半胱天冬酶如半胱天冬酶-7,并通过BIR3结构域抑制起始半胱天冬酶如半胱天冬酶-9。一种在凋亡过程中释放的线粒体蛋白Smac/DIABLO,通过与XIAP直接相互作用来拮抗XIAP介导的半胱天冬酶抑制作用。在此,我们利用谷胱甘肽S-转移酶下拉实验和半胱天冬酶活性测定表明,Smac在缓解XIAP结构域片段对半胱天冬酶-7或半胱天冬酶-9的抑制方面无效。此外,Smac与半胱天冬酶-7和连接子_BIR2形成三元复合物,这表明Smac/连接子_BIR2相互作用在空间上并不排除连接子_BIR2/半胱天冬酶-7相互作用。然而,Smac在去除含有BIR2和BIR3结构域的XIAP片段对半胱天冬酶-7和半胱天冬酶-9的抑制方面是有效的。表面等离子体共振测量表明,Smac以微摩尔解离常数与BIR2或BIR3结构域相互作用。另一方面,Smac通过Smac二聚体与单个XIAP分子的BIR2和BIR3结构域同时相互作用,以亚纳摩尔解离常数与含有BIR2和BIR3结构域的XIAP构建体相互作用。这种2:1的Smac/XIAP相互作用不仅具有增强的亲和力,而且在空间上排除了XIAP/半胱天冬酶-7相互作用,证明了Smac缓解XIAP介导的半胱天冬酶抑制需要BIR2和BIR3结构域。

相似文献

1
Requirement of both the second and third BIR domains for the relief of X-linked inhibitor of apoptosis protein (XIAP)-mediated caspase inhibition by Smac.凋亡抑制蛋白(XIAP)介导的半胱天冬酶抑制作用的解除对Smac的第二个和第三个BIR结构域的需求。
J Biol Chem. 2003 Dec 5;278(49):49517-22. doi: 10.1074/jbc.M310061200. Epub 2003 Sep 25.
2
Engineering ML-IAP to produce an extraordinarily potent caspase 9 inhibitor: implications for Smac-dependent anti-apoptotic activity of ML-IAP.工程化改造ML-IAP以产生一种极其有效的半胱天冬酶9抑制剂:对ML-IAP的Smac依赖性抗凋亡活性的影响。
Biochem J. 2005 Jan 1;385(Pt 1):11-20. doi: 10.1042/BJ20041108.
3
A dimeric Smac/diablo peptide directly relieves caspase-3 inhibition by XIAP. Dynamic and cooperative regulation of XIAP by Smac/Diablo.一种二聚体Smac/暗黑破坏神肽可直接解除XIAP对caspase-3的抑制作用。Smac/暗黑破坏神对XIAP的动态协同调节。
J Biol Chem. 2007 Oct 19;282(42):30718-27. doi: 10.1074/jbc.M705258200. Epub 2007 Aug 27.
4
Design and characterization of bivalent Smac-based peptides as antagonists of XIAP and development and validation of a fluorescence polarization assay for XIAP containing both BIR2 and BIR3 domains.基于Smac的双价肽作为XIAP拮抗剂的设计与表征以及针对包含BIR2和BIR3结构域的XIAP的荧光偏振测定法的开发与验证。
Anal Biochem. 2008 Mar 1;374(1):87-98. doi: 10.1016/j.ab.2007.10.032. Epub 2007 Nov 20.
5
Structural insight into inhibitor of apoptosis proteins recognition by a potent divalent smac-mimetic.结构洞察凋亡蛋白抑制剂识别的有效双价 smac-模拟物。
PLoS One. 2012;7(11):e49527. doi: 10.1371/journal.pone.0049527. Epub 2012 Nov 15.
6
Smac3, a novel Smac/DIABLO splicing variant, attenuates the stability and apoptosis-inhibiting activity of X-linked inhibitor of apoptosis protein.Smac3是一种新型的Smac/DIABLO剪接变体,可减弱X连锁凋亡抑制蛋白的稳定性和凋亡抑制活性。
J Biol Chem. 2003 Dec 26;278(52):52660-72. doi: 10.1074/jbc.M308036200. Epub 2003 Sep 30.
7
A mechanistic insight into SMAC peptide interference with XIAP-Bir2 inhibition of executioner caspases.对SMAC肽干扰XIAP-Bir2抑制凋亡执行蛋白酶的机制性洞察。
J Mol Biol. 2008 Sep 5;381(3):645-54. doi: 10.1016/j.jmb.2008.05.082. Epub 2008 Jun 7.
8
Interaction of a cyclic, bivalent smac mimetic with the x-linked inhibitor of apoptosis protein.一种环状二价Smac模拟物与X连锁凋亡抑制蛋白的相互作用
Biochemistry. 2008 Sep 16;47(37):9811-24. doi: 10.1021/bi800785y. Epub 2008 Aug 22.
9
Design, synthesis, and characterization of a potent, nonpeptide, cell-permeable, bivalent Smac mimetic that concurrently targets both the BIR2 and BIR3 domains in XIAP.一种强效、非肽、可穿透细胞的双价Smac模拟物的设计、合成与表征,该模拟物同时靶向XIAP中的BIR2和BIR3结构域。
J Am Chem Soc. 2007 Dec 12;129(49):15279-94. doi: 10.1021/ja074725f. Epub 2007 Nov 14.
10
A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis.半胱天冬酶 -9和Smac/DIABLO中一个保守的XIAP相互作用基序调节半胱天冬酶活性和细胞凋亡。
Nature. 2001 Mar 1;410(6824):112-6. doi: 10.1038/35065125.

引用本文的文献

1
Blocking XIAP:CASP7-p19 selectively induces apoptosis of CASP3/DR malignancies by a novel reversible small molecule.阻断XIAP:CASP7-p19可通过一种新型可逆小分子选择性诱导CASP3/DR恶性肿瘤细胞凋亡。
Cell Death Dis. 2025 Jun 18;16(1):459. doi: 10.1038/s41419-025-07774-y.
2
Interaction of SMAC with a survivin-derived peptide alters essential cancer hallmarks: Tumor growth, inflammation, and immunosuppression.SMAC 与 survivin 衍生肽相互作用改变了关键的癌症特征:肿瘤生长、炎症和免疫抑制。
Mol Ther. 2024 Jun 5;32(6):1934-1955. doi: 10.1016/j.ymthe.2024.04.007. Epub 2024 Apr 5.
3
Recent advances in targeting the "undruggable" proteins: from drug discovery to clinical trials.
靶向“不可成药”蛋白的最新进展:从药物发现到临床试验。
Signal Transduct Target Ther. 2023 Sep 6;8(1):335. doi: 10.1038/s41392-023-01589-z.
4
Characterization of a Potent and Orally Bioavailable Lys-Covalent Inhibitor of Apoptosis Protein (IAP) Antagonist.一种强效、口服生物可利用的半胱天冬酶蛋白酶(caspase)-募集结构域(CARD)结合凋亡蛋白(IAP)拮抗剂的鉴定。
J Med Chem. 2023 Jun 22;66(12):8159-8169. doi: 10.1021/acs.jmedchem.3c00467. Epub 2023 Jun 1.
5
DCAF12 promotes apoptosis and inhibits NF-κB activation by acting as an endogenous antagonist of IAPs.DCAF12 通过作为 IAPs 的内源性拮抗剂促进细胞凋亡并抑制 NF-κB 激活。
Oncogene. 2022 May;41(21):3000-3010. doi: 10.1038/s41388-022-02319-5. Epub 2022 Apr 22.
6
A Review of the Current Impact of Inhibitors of Apoptosis Proteins and Their Repression in Cancer.凋亡蛋白抑制剂及其在癌症中的抑制作用的当前影响综述
Cancers (Basel). 2022 Mar 25;14(7):1671. doi: 10.3390/cancers14071671.
7
XIAP's Profile in Human Cancer.XIAP 在人类癌症中的特征。
Biomolecules. 2020 Oct 29;10(11):1493. doi: 10.3390/biom10111493.
8
Stability and Cell Permeability of Sulfonyl Fluorides in the Design of Lys-Covalent Antagonists of Protein-Protein Interactions.磺酰氟的稳定性和细胞通透性在设计赖氨酸半胱氨酸共价拮抗蛋白-蛋白相互作用中的作用。
ChemMedChem. 2020 Nov 18;15(22):2176-2184. doi: 10.1002/cmdc.202000355. Epub 2020 Oct 13.
9
Monoglyceride lipase mediates tumor-suppressive effects by promoting degradation of X-linked inhibitor of apoptosis protein.单酰甘油脂肪酶通过促进凋亡抑制蛋白 X 连锁蛋白的降解来发挥肿瘤抑制作用。
Cell Death Differ. 2020 Oct;27(10):2888-2903. doi: 10.1038/s41418-020-0549-5. Epub 2020 May 6.
10
IAP-Mediated Protein Ubiquitination in Regulating Cell Signaling.IAP 介导的蛋白质泛素化在调节细胞信号转导中的作用。
Cells. 2020 Apr 30;9(5):1118. doi: 10.3390/cells9051118.